The Dow Chemical Company’s investment in OxyMem Ltd. accelerates the commercialization of OxyMem’s wastewater treatment technology, Membrane Aerated Biofilm Reactor (MABR). MABR technology has the potential to bring wastewater treatment closer to energy neutrality by reducing energy consumption for aeration by up to 75%, according to Dow.
“Global water demand trends are making wastewater infrastructure a major challenge for populations and industries across the globe,” says Snehal Desai, global business director for Dow Water and Process Solutions. “OxyMem’s MABR technology shows excellent promise in lowering operational costs for the wastewater treatment process due to reduced energy demand. This also makes the technology a strong sustainability value proposition; it can help encourage greater adoption of water reuse and as a result, advance a circular economy that makes water a well-managed resource, sustained by advances in science and technology.”
For more information, visit: www.dow.com
